Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 4/2008

01-04-2008 | Original

Early coagulation disorders after severe burn injury: impact on mortality

Published in: Intensive Care Medicine | Issue 4/2008

Login to get access

Abstract

Objective

To evaluate the time course of coagulation markers in the early postburn period and clarify the role of coagulation alterations in organ failure and in mortality prognosis.

Design and setting

This prospective study was conducted in the burn ICU of a tertiary hospital.

Patients

45 patients with severe thermal burn injury.

Measurements and results

Clinical data and coagulation and fibrinolysis parameters were measured during the first postburn week. The ICU 28-day mortality rate was 33%. Significant differences in the time course of coagulation markers were observed between survivors and nonsurvivors. SOFA score distinguished between patients with overt and nonovert disseminated intravascular coagulation (DIC) during the overall investigation period. Presence of overt DIC was related to mortality (OR = 0.1). Antithrombin, protein S, plasminogen activator inhibitor 1, and SOFA score on day 3, protein C on day 5, and thrombin/antithrombin complexes on day 7 revealed a good prognostic value for ICU mortality, according to the area under ROC curves.

Conclusions

Severe thermal injury is associated with the early activation of coagulation cascade, presence of DIC, organ failure, and increased mortality.
Literature
1.
Shankar R, Amin C, Gamelli RL (2002) Hematologic, hematopoetic, and acute phase response. In: Herndon D (ed) Total burn care, 2nd edn. Saunders, Harcourt New York, pp 331–346
2.
Opal SM (2000) Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med 28:S77–S80PubMedCrossRef
3.
Heideman M (1979) The effect of thermal injury on hemodynamic, respiratory, and hematologic variables in relation to complement activation. J Trauma 19:239–247PubMed
4.
Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E (2001) Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med 29:134–139PubMedCrossRef
5.
Bartlett RH, Fong SV, Maruggo G, Hardeman T, Anderson V (1981) Coagulation and platelets changes after thermal injury in man. Burns 7:370–377CrossRef
6.
Wells S, Sissons M, Hasleton PS (1984) Quantitation of pulmonary megakaryocytes and fibrin thrombi in patients dying from burns. Histopathology 8:517–527PubMedCrossRef
7.
Kowal-Vern A, Gamelli RL, Walenga JM, Hoppensteadt D, Sharp-Pucci M, Schumacher HR (1992) The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state. J Trauma 33:50–56PubMed
8.
Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M (2001) Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330PubMed
9.
Bakhtiari K, Meijers JC, de Jonge E, Levi M (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32:2416–2421PubMedCrossRef
10.
Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group (2006) A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 34:625–631PubMed
11.
Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, Keinecke HO, Warren BL, Opal SM, KyberSept investigators (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90–97PubMedCrossRef
12.
Sivula M, Tallgren M, Pettila V (2005) Modified score for disseminated intravascular coagulation in the critically ill. Intensive Care Med 31:1209–1214PubMedCrossRef
13.
Garcia-Avello A, Lorente JA, Cesar-Perez J, Garcia-Frade LJ, Alvarado R, Arevalo JM, Navarro JL, Esteban A (1998) Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res 89:59–64PubMedCrossRef
14.
15.
Kollef MH, Eisenberg PR, Shannon W (1998) A rapid assay for the detection of circulating D-dimer is associated with clinical outcomes among critically ill patients. Crit Care Med 26:1054–1060PubMedCrossRef
16.
Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O (1998) Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 26:2005–2009PubMedCrossRef
17.
Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 25:686–696PubMedCrossRef
18.
Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2:1924–1933PubMedCrossRef
19.
Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG (2001) Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med 27:1853–1859PubMedCrossRef
20.
Barret JP, Gomez PA (2005) Disseminated intravascular coagulation: a rare entity in burn injury. Burns 31:354–357PubMedCrossRef
21.
Aoki K, Aikawa N, Sekine K, Yamazaki M, Mimura T, Urano T, Takada A (2001) Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns. Burns 27:569–575PubMedCrossRef
22.
Kowal-Vern A, McGill V, Walenga JM, Gamelli RL (2000) Antithrombin (H) concentrate infusions are safe and effective in patients with thermal injuries. J Burn Care Rehabil 21:115–127PubMedCrossRef
23.
Hesselvik JF, Blomback M, Brodin B, Maller R (1989) Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med 17:724–733PubMedCrossRef
24.
Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A (1993) Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103:1536–1542PubMedCrossRef
25.
Aoki K, Nishino N, Baba S, Urano T, Takada A (1994) Postoperative changes in plasma tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. Surg Today 24:1039–1043PubMedCrossRef
26.
Watanabe R, Wada H, Watanabe Y, Sakakura M, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Nobori T, Shiku H (2001) Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. Thromb Res 104:1–6PubMedCrossRef
27.
Soejima K, Schmalstieg FC, Sakurai H, Traber LD, Traber DL (2001) Pathophysiological analysis of combined burn and smoke inhalation injuries in sheep. Am J Physiol Lung Cell Mol Physiol 280:L1233–L1241PubMed
28.
Murakami K, McGuire R, Cox RA, Jodoin JM, Schmalstieg FC, Traber LD, Hawkins HK, Herndon DN, Traber DL (2003) Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep. Crit Care Med 31:577–583PubMedCrossRef
Metadata
Title
Early coagulation disorders after severe burn injury: impact on mortality
Publication date
01-04-2008
Published in
Intensive Care Medicine / Issue 4/2008
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-007-0976-5

Other articles of this Issue 4/2008

Intensive Care Medicine 4/2008 Go to the issue

Brief Report

In vitro validation of a novel methodfor continuous intra-abdominalpressure monitoring

Original

Intra-abdominal hypertensionand acute renal failurein critically ill patients

Brief Report

Transvesical intra-abdominal pressure measurement using minimal instillation volumes: how low can we go?

Mini Series: Basic research-related topics in ICM

Effects of mechanical ventilation on the extracellular matrix

Original

Extracranial complications in patients with acute brain injury: a post-hoc analysis of the SOAP study

Editorial

ARDS and knowledge translation